Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Noralin
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.12mg/mL equivalent to noradrenaline 0.06mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Sintetica-Bioren SA, Couvet, Switzerland
   
Product: Noralin
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.2mg/mL equivalent to noradrenaline 0.1mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Sintetica-Bioren SA, Couvet, Switzerland
   
Product: Noralin
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.24mg/mL equivalent to noradrenaline 0.12mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Sintetica-Bioren SA, Couvet, Switzerland
   
Product: Noralin
Active Ingredient: Noradrenaline acid tartrate monohydrate 0.4mg/mL equivalent to noradrenaline 0.2mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Boucher & Muir (New Zealand) Limited t/a BNM Group
Manufacturer: Sintetica-Bioren SA, Couvet, Switzerland


Dated this 5th day of August 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).